The professor of medicine at Washington University School of Medicine in St. Louis discussed the potential utility of frontline CAR T-cell therapy in mantle cell lymphoma.
Brad S. Kahl, MD
Advertisement
Articles by Brad S. Kahl, MD
Brad S. Kahl, MD, discusses remaining challenges with CAR T-cell therapy in diffuse large B-cell lymphoma.
This video reviews different strategies for maintenance therapy in mantle cell lymphoma, as well as highlighting upcoming research in this setting.
Advertisement
Latest Updated Articles
Maintenance Therapy in Mantle Cell LymphomaPublished: July 7th 2017 | Updated:
Dr. Kahl on Remaining Challenges With CAR T-Cell Therapy in DLBCLPublished: December 8th 2020 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
Around the Helix: Cell and Gene Therapy Company Updates – October 29, 2025
2
Intellia Puts Phase 3 Trials for Transthyretin Amyloidosis Gene Editing Therapy Nex-Z on Hold Following Grade 4 Liver AE
3
Quarter Century Update: What Lessons Should Guide the Next Generation of Developers and Regulators?
4
Quarter Century Update: What Does the Field Need Most Right Now?
5
